Unresolved inflammation is a hallmark of many deadly diseases including atherosclerosis, a
silent pathological condition behind majority of cardiovascular diseases. Yet, anti …

Atherosclerosis is a chronic inflammatory disease and the major pathological factor of most
cardiovascular diseases, leading to≈ 1/3 of deaths worldwide. Improving local delivery of …

Inflammation is an essential protective biological response involving a coordinated cascade
of signals between cytokines and immune signaling molecules that facilitate return to tissue …

Administration of drugs and other therapeutic agents has been the central strategy of
contemporary medicine for cardiovascular disease. The use of drug delivery systems (DDS) …

Vascular disease remains the leading cause of death and disability, the etiology of which
often involves atherosclerosis. The current treatment of atherosclerosis by pharmacotherapy …

Atherosclerosis is the leading cause of many fatal cardiovascular and cerebrovascular
diseases. Whereas nanomedicines are promising for targeted therapy of atherosclerosis …

Nanoparticle-based therapeutics represent potential strategies for treating atherosclerosis;
however, the complex plaque microenvironment poses a barrier for nanoparticles to target …

Chronic inflammatory microenvironment is the predominant milieu that promotes the
progression of atherosclerosis (AS). However, targeted regulation of the chronic …

Atherosclerosis is the underlying cause for cardiovascular disease. Current
pharmacotherapies are limited by the inadequate targeting and insufficient treatment …

Immunomodulatory therapy has become a promising method for the clinical treatment of
many diseases. Recently, pilot studies revealed that immunomodulatory therapy exhibited …